News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
74,224 Results
Type
Article (904)
Company Profile (7)
Press Release (73313)
Section
Business (23560)
Career Advice (31)
Deals (5814)
Drug Delivery (1)
Drug Development (10273)
Employer Resources (3)
FDA (1192)
Job Trends (1210)
News (39665)
Policy (2663)
Tag
Academia (126)
Accelerated approval (2)
Allergies (7)
Alliances (3457)
ALS (4)
Alzheimer's disease (101)
Antibody-drug conjugate (ADC) (11)
Approvals (1234)
Artificial intelligence (8)
Autoimmune disease (9)
Automation (1)
Bankruptcy (48)
Best Places to Work (1133)
Biosimilars (2)
Biotechnology (4)
Bladder cancer (18)
Brain cancer (2)
Breast cancer (52)
Cancer (367)
Cardiovascular disease (38)
Career advice (31)
CAR-T (15)
Cell therapy (35)
Cervical cancer (1)
Clinical research (8926)
Collaboration (69)
Compensation (132)
Complete response letters (1)
COVID-19 (166)
CRISPR (1)
C-suite (43)
Cystic fibrosis (21)
Data (588)
Depression (11)
Diabetes (28)
Diagnostics (507)
Digital health (5)
Drug discovery (5)
Drug pricing (2)
Duchenne muscular dystrophy (29)
Earnings (16193)
Employer resources (2)
Events (13832)
Executive appointments (47)
FDA (1463)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (61)
Gene editing (4)
Gene therapy (14)
GLP-1 (26)
Government (244)
Guidances (111)
Healthcare (1964)
Huntington's disease (1)
IgA nephropathy (12)
Immunology and inflammation (22)
Immuno-oncology (1)
Indications (5)
Infectious disease (189)
Inflammatory bowel disease (17)
Influenza (16)
Intellectual property (18)
Interviews (9)
IPO (4311)
Job creations (138)
Job search strategy (30)
Labor market (1)
Layoffs (12)
Legal (671)
Liver cancer (6)
Lung cancer (44)
Lymphoma (26)
Management (1)
Manufacturing (28)
MASH (24)
Medical device (1412)
Medtech (1418)
Mergers & acquisitions (1632)
Metabolic disorders (74)
Multiple sclerosis (15)
Neurodegenerative disease (13)
Neuropsychiatric disorders (3)
Neuroscience (170)
NextGen: Class of 2026 (463)
Non-profit (213)
Obesity (22)
Opinion (4)
Ovarian cancer (25)
Pain (6)
Pancreatic cancer (24)
Parkinson's disease (13)
Partnered (2)
Patents (38)
Patient recruitment (12)
Peanut (3)
People (4719)
Pharmacy benefit managers (1)
Phase 1 (2565)
Phase 2 (4026)
Phase 3 (3050)
Pipeline (678)
Policy (1)
Postmarket research (308)
Preclinical (1028)
Press Release (1)
Prostate cancer (14)
Radiopharmaceuticals (41)
Rare diseases (56)
Real estate (243)
Recruiting (2)
Regulatory (1996)
Research institute (109)
Resumes & cover letters (2)
RSV (4)
Schizophrenia (9)
Series A (8)
Series B (12)
Service/supplier (2)
Sickle cell disease (3)
Special edition (1)
Spinal muscular atrophy (16)
Startups (171)
Supply chain (5)
Tariffs (1)
Vaccines (37)
Venture capital (1)
Weight loss (7)
Women's health (3)
Date
Last 7 days (67)
Last 30 days (150)
Last 365 days (2917)
2026 (243)
2025 (3016)
2024 (3760)
2023 (4566)
2022 (7007)
2021 (7260)
2020 (9877)
2019 (4751)
2018 (3469)
2017 (3569)
2016 (2704)
2015 (3916)
2014 (2402)
2013 (1398)
2012 (1747)
2011 (1835)
2010 (1435)
Location
Africa (31)
Alabama (17)
Arizona (17)
Asia (4251)
Australia (522)
California (1315)
Canada (186)
China (80)
Colorado (40)
Connecticut (51)
Delaware (69)
Europe (7287)
Florida (189)
Georgia (20)
Illinois (78)
India (2)
Indiana (29)
Japan (18)
Kansas (11)
Kentucky (2)
Louisiana (4)
Maine (3)
Maryland (102)
Massachusetts (830)
Michigan (23)
Minnesota (63)
Missouri (9)
Montana (1)
Nebraska (1)
Nevada (7)
New Hampshire (8)
New Jersey (423)
New York (468)
North Carolina (160)
Northern California (591)
Ohio (12)
Pennsylvania (223)
Rhode Island (1)
South America (63)
South Carolina (1)
Southern California (595)
Tennessee (6)
Texas (206)
United States (4418)
Utah (26)
Virginia (77)
Washington D.C. (2)
Washington State (49)
Wisconsin (3)
74,224 Results for "212".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enlivex Announces Closing of Previously Announced $212,000,000 Private Placement
November 27, 2025
·
5 min read
Press Releases
Solid Biosciences Receives FDA Orphan Drug Designation for SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia
January 13, 2026
·
7 min read
Press Releases
AdvanCell Announces Collaboration and Exclusive Licensing Agreement with 48Hour Discovery to Develop a Novel Peptide-Based Lead-212 Radiotherapeutic for a Gastrointestinal Cancer with Significant Medical Need
February 2, 2026
·
3 min read
Press Releases
Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE)
January 8, 2026
·
3 min read
Press Releases
Virometix AG Announces Positive Data from Phase 1 Trial of V-212, a Fully Synthetic, Serotype-Independent Vaccine Development Candidate for the Prevention of Pneumococcal Disease
January 8, 2026
·
4 min read
Press Releases
Leads Biolabs And Dianthus Therapeutics Announce Initiation of Phase 1 Trial Of LBL-047 (DNTH212) In Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)
December 24, 2025
·
8 min read
Press Releases
Solid Biosciences Doses First Participant in First-in-Class Phase 1b FALCON Trial Evaluating SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia
January 12, 2026
·
7 min read
Press Releases
Solid Biosciences Receives FDA Rare Pediatric Disease Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia
December 2, 2025
·
7 min read
Press Releases
Virometix AG Announces Completion of $15 Million Financing Round to Advance Development of V-212 and Next-Generation Synthetic Vaccines
November 13, 2025
·
2 min read
Press Releases
AdvanCell to Highlight the Potential of Pb-212-based Targeted Alpha Therapies for Cancer at EANM’25
September 29, 2025
·
3 min read
1 of 7,423
Next
